Tropical Health Department, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
Epidemiol Infect. 2020 Feb 14;148:e28. doi: 10.1017/S0950268820000175.
We have previously shown that the Egyptian Hepatitis C Virus Risk Score (EGCRISC), an Egyptian hepatitis C virus (HCV) risk-based screening tool, to be valid and cost-effective. Certain behaviours, occupations and diseases have been shown to be associated with an increased risk of exposure to HCV infection and constitute a major population reservoir of HCV infection. This study investigated the efficacy of EGCRISC in selected high-risk groups by testing 863 participants from four groups: slaughterhouse workers, illicit drug users (IDUs), female sex workers and human immune deficiency virus (HIV) patients. Data for this study were collected on EGCRISC and another pre-designed risk factor questionnaire. Sera were tested for HCV antibodies by ELISA. EGCRISC, at lower cut-off points, showed significantly good performance (P < 0.05) in all four groups except for females <45 years, but was reliable in detecting HCV cases (sensitivity: 84.21% and negative predictive value: 94.5%). Specific scores for IDUs and HIV patients were developed that showed high accuracy (P < 0.001). A modified EGCRISC for high-risk groups (EGCRISC-HRGs) was shown to be a valid tool that is recommended for use in high-risk populations if no other specific screening tool is available or universal screening is applied. EGCRISC for IDUs (EGCRISC-IDUs) and EGCRISC for HIV patients (EGCRISC-HIV) are useful tools for preselecting potentially HCV-infected cases for further testing in settings where serological analysis is not readily available or accessible.
我们之前已经证明,埃及丙型肝炎病毒风险评分(EGCRISC)是一种基于埃及丙型肝炎病毒(HCV)风险的筛查工具,具有有效性和成本效益。某些行为、职业和疾病已被证明与感染 HCV 的风险增加有关,是 HCV 感染的主要人群储库。本研究通过对来自四个群体的 863 名参与者(屠宰场工人、非法药物使用者(IDU)、性工作者和人类免疫缺陷病毒(HIV)患者)进行检测,研究了 EGCRISC 在选定高危人群中的疗效。本研究的数据是通过 EGCRISC 和另一个预先设计的风险因素问卷收集的。通过 ELISA 检测 HCV 抗体。EGCRISC 在所有四个群体(45 岁以下女性除外)中,在较低的截止点显示出明显的良好性能(P<0.05),但在检测 HCV 病例方面是可靠的(灵敏度:84.21%和阴性预测值:94.5%)。为 IDU 和 HIV 患者开发了特定的评分,显示出很高的准确性(P<0.001)。一种用于高危人群的改良 EGCRISC(EGCRISC-HRGs)被证明是一种有效的工具,如果没有其他特定的筛查工具可用或应用普遍筛查,则推荐在高危人群中使用。用于 IDU 的 EGCRISC(EGCRISC-IDUs)和用于 HIV 患者的 EGCRISC(EGCRISC-HIV)是用于预筛选可能感染 HCV 的病例的有用工具,以便在无法或无法获得血清学分析的情况下进行进一步检测。